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Neurons Controls Epidermal Innervation by Interaction with
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Dieter R. Zimmermann,2 and Christine E. Bandtlow1
1Division of Neurobiochemistry, Biocenter, Innsbruck Medical University, 6020 Innsbruck, Austria and 2Institute of Surgical Pathology, University Hospital
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Primary sensory afferents of the dorsal root ganglion (DRG) that innervate the skin detect a wide range of stimuli, such as touch,
temperature, pain, and itch. Different functional classes of nociceptors project their axons to distinct target zones within the developing
skin, but the molecular mechanisms that regulate target innervation are less clear. Here we report that the Nogo66 receptor homolog
NgR2 is essential for proper cutaneous innervation. NgR2/ mice display increased density of nonpeptidergic nociceptors in the
footpad and exhibit enhanced sensitivity tomechanical force and innocuous cold temperatures. These sensory deficits are not associated
with any abnormality inmorphology or density of DRGneurons. However, deletion of NgR2 renders nociceptive nonpeptidergic sensory
neurons insensitive to the outgrowth repulsive activity of skin-derived Versican. Biochemical evidence shows that NgR2 specifically
interacts with the G3 domain of Versican. The data suggest that Versican/NgR2 signaling at the dermo-epidermal junction acts in vivo as
a local suppressor of axonal plasticity to control proper density of epidermal sensory fiber innervation. Our findings not only reveal the
existence of a novel and unsuspected mechanism regulating epidermal target innervation, but also provide the first evidence for a
physiological role of NgR2 in the peripheral nervous system.
Introduction
Sensory neurons of the dorsal root ganglion (DRG) that inner-
vate the skin allow the detection of mechanical, thermal, itchy,
and painful sensations. These different sensory modalities are
reported to postsynaptic neurons in the spinal cord and subse-
quently to the brain. In adult mice, two of the major subpopula-
tions of DRG sensory neurons are specialized for nociception.
They exhibit different molecular characteristics and require dif-
ferent target-derived trophic factors for their survival, differenti-
ation and maintenance (Basbaum et al., 2009). Peptidergic
nociceptors express the neuropeptide calcitonin gene-related
peptide (CGRP) and respond to nerve growth factor (NGF),
whereas nonpeptidergic nociceptors express the purinergic re-
ceptor P2X3, bind the isolectin B4 (IB4), and respond to glial-
derived neurotrophic factor (GDNF) family ligands (GFLs;
Molliver et al., 1995; Priestley et al., 2002). Anatomically, axons of
both populations of DRG neurons terminate in different central
and peripheral target layers (Zylka et al., 2005), suggesting that
they exhibit distinct functional properties. Although target-
derived neurotrophic factors control at large epidermal fiber
density, repulsive cues such as semaphorins, ephrins or extracel-
lular matrix (ECM) molecules at the dermo-epidermal junction
(DEJ)may also have instructive roles in targeting decisions (Moss
et al., 2005; Tominaga et al., 2008; Chiang et al., 2011). Prominent
components of the skin ECM are the chondroitin-sulfate pro-
teoglycans (CSPG) Versican V0 and V1 (Zimmermann et al.,
1994), which act as repellent factors to sensory axons in vitro
(Dutt et al., 2011), suggesting that their biological function may
be to prevent sensory axons from crossing into inappropriate
territory. As abnormalities in sensory innervation are often asso-
ciated with abnormal perception of itch and pain, a detailed
understanding of the molecular mechanisms involved in estab-
lishing and maintaining correct nociceptive innervation is of
considerable interest.
NgR2 is a member of the Nogo66 receptor NgR family that
consists of three structurally related proteins, NgR1–3 (Laure´n et
al., 2003). NgR1 and NgR2 were identified as axonal glycosyl-
phosphatidylinositol-anchored proteins with specific binding
properties for myelin-associated growth inhibitors in the CNS
(Fournier et al., 2001; Wang et al., 2002; Venkatesh et al., 2005).
In addition, NgR1 and NgR3, but not NgR2, were shown to as-
sociate with selective glycosaminoglycan (GAG) side chains of
CSPGs (Dickendesher et al., 2012). NgRs, in particular NgR1,
have attracted considerable interest because of their suggested
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role in restricting axon collateral sprouting after injury and lim-
iting structural synaptic plasticity in the intact CNS (Mironova
and Giger, 2013). However, examining the functional relevance
of NgR2 in vivo has proven challenging because of the potential
redundancy with other NgRs (Wo¨rter et al., 2009, Wills et al.,
2012) and the lack of unequivocally identified specific ligands.
We show that NgR2 on sensory DRG neurons is required for
proper skin innervation. NgR2/ mice display increased affer-
ent density of nonpeptidergic nociceptors in the footpad, accom-
panied by increased responses to noxious mechanical forces and
innocuous cold sensation. NgR2 binds to the protein core of
Versican and is necessary to render nonpeptidergic sensory neu-
rons sensitive toVersican inhibition.Our data suggest thatNgR2/
Versican signaling acts to locally suppress sensory terminal
branching at the DEJ.
Materials andMethods
Plasmids
Full-length human myelin oligodendrocyte glycoprotein (MOG) cDNA
was kindly provided by Markus Reindl, Innsbruck. Untagged human
Versican V0 and V1 plasmids (Dours-Zimmermann and Zimmermann,
1994) and Nogo-myc (Oertle et al., 2003) have been described. Full-
length human Versican V3 cDNAwas generated by reverse transcription
(RT)-PCR from primary cultured fibroblasts with the primers: forward
5-AAGAAGGCCCAGCCGGCCCTACATAAAGTCAAAGTGGGA-3;
reverse 5-AAGAATCTAGACCGGCCCTCGATGCGCCTCGACTC-3.
The resulting product was cloned into SfiI/XbaI digested pSecTag-A vec-
tor (Invitrogen). The final construct carries a Factor Xa cleavage site at
the 3 end, followed by myc- and 6xHis-tags from the vector.
Versican constructs encompassing either of the globular domains G1
(ENSEMBLVCAN-005 ENST00000502527 c.VCANV3 nucleotides 60–
1041) or G3 (nucleotides 1043–1966) were prepared analogously using
the human Versican V3 (Zako et al., 1995) construct as template. The
primers for the PCR amplification of G1 were as follows: forward 5-
ATAGGCCCAGCCGGCCCTACATAAAGTCAAAGTG-3; reverse 5-
CCGTCTAGATTTAAAGCAGTAGGCATC-3 and for G3: forward
5-ATAGGCCCAGCCGGCCGGACCTGATCGCTGCAAA-3 and re-
verse 5-CCGTCTAGAGCGCCTCGACTCCTGCCA-3. PCR products
were cloned into the pSecTag (Invitrogen). NgR2-mFc encompassing
the ectodomain of mouse NgR2 including the signal peptide (nucleo-
tides 1–1168; forward 5-TATAAGCTTACCATGCTGCCCGGGCTCC
GGC-3 and reverse 5-TATGCGGCCGCCACGCGGCCCCGGGA
CACGTCTG-3) was generated by PCR amplification and cloned into
pCMV6-AC-Fc (OriGene) using the HindIII-NotI sites of the vector. To
generate NgR2-hFc, the murine Fc-tag was replaced with the human
Fc-tag using the XhoI-FseI sites of the vector. The following primers were
used: forward 5-CCGCTCGAGCCCAAATCTTGT-3 and reverse 5-
GTAGGCCGGCCTCATTTACCCGGAGA-3. Restriction sites used for
subcloning are underlined. All constructs were verified by sequencing
analysis (LGC).
Animals and ethics statement
NgR2-null mice have been described previously (Wo¨rter et al., 2009).
Wild-type (WT) littermate controls and NgR2/ animals were ob-
tained by mating heterozygous NgR2/ animals. All animal experi-
ments have been performed with permission of the Austrian Federal
Ministry for Science and Research (ref. BMWF-66.011/0085-C/GT/
2007) and in accordance with the ethical guidelines of the International
Association for the Study of Pain.
Nociceptive tests were performed as described previously (Lagerstro¨m
et al., 2011). Adult (8 weeks) male NgR2/ mice (n  8) and WT
littermate controls (n  8) from an inbred colony in a C57BL/6J back-
ground were used in the experiments. Mice were housed on a 12 h light/
dark cycle with mouse chow and water ad libitum. All behavioral studies
were conducted as blind experiments.
Randall–Selitto test. The test was performed on one mouse at a time as
described previously (Lagerstro¨m et al., 2011). Mice were trained for 2 d
and tested on the third day. The hindpaw was gently placed under the
Randall–Selitto arm (UgoBasile) before an increasingweightwas applied
to the paw. The cutoff was set to 250 g. The weight at which the mouse
withdrew its paw was recorded and the result expressed as the mean
withdrawal latency in grams for each animal and group SEM. Statisti-
cal significance was determined by a Mann–Whitney U test.
Hot-plate test.Mice were acclimatized to the hot plate (Ugo Basile) at
room temperature (21°C) for 5 min the day before testing. On the test
day, the latency of withdrawal of the hindpaw at 56°C followed by lifting,
licking, or biting of the paw was measured as described previously (La-
gerstro¨m et al., 2011). Results are expressed as mean withdrawal latency
for each animal and group  SEM. Statistical significance was deter-
mined by a Mann–Whitney U test.
Cold-plate test. Mice were acclimatized to the plate (21°C) for 5 min
the day before testing. On the test day, the plate was cooled to 10°C and
hindpaw lifts not associated with general movement were recorded as
response over 5 min. Results are expressed as mean withdrawal latency
for each animal and group  SEM. Statistical significance was deter-
mined by a Mann–Whitney U test.
Thermal preference test.Mice were placed into a chamber consisting of
two adjacent metal plates at controlled temperatures (Ugo Basile) and
allowed to explore the test arena with both surfaces set at 30°C for 5 min
the day before testing. Preference testing was performed as described
by holding one plate at a constant temperature of 30°C, and the other
ranged in temperature from 10 to 30°C in 5°C steps (test plate; Bau-
tista et al., 2007). To assess the avoidance of heat one assay was per-
formed with the test plate set at 49°C. Voluntary movement of mice
between plates was recorded over 5 min by tallying the cumulative
time spent on each plate. Data are expressed as the percentage of time
in seconds spent on the 30°C plate over a 5 min period for each animal
and group  SEM. Statistical significance was determined by a
Mann–Whitney U test at each temperature.
In situ hybridization
An 800 bp RT-PCR product corresponding to nucleotides 481–1263
of murine NgR2 was cloned into pBluescript and pCRII-TOPO vec-
tor, respectively. Sense and antisense cRNA probes were transcribed
by T7 and T3 RNA polymerases, respectively. Transcription reactions
took place in the presence of digoxigenin (DIG)-uridine triphosphate
using a DIG RNA labeling kit (Roche Diagnostics) according to the
manufacturer’s instructions. Cryostat sections (20 m) from lumbar
DRGs (L4–L5) were obtained from adult C57BL/6 mice, thawed on
poly-lysine-coated slides (Thermo Scientific), and fixed with 2%
paraformaldehyde (PFA) in PBS at 4°C for 15 min. In situ hybridiza-
tion (ISH) was performed as described previously (Bourane et al.,
2007). After permeabilization with 0.05 M HCl and acetylation with
0.25% acetic anhydrate in 0.1 M triethanolamine, sections were hy-
bridized with DIG-labeled riboprobes (1 ng/l) overnight at 70°C.
After washing with 1 SSC, 50% formamide, 0.1% Tween at 65°C,
and with 100 mM maleic acid, 150 mM NaCl, and 0.1% Tween at room
temperature, sections were blocked with 10% normal goat serum and
1% blocking reagent (Roche) in PBS. Hybridized probes were de-
tected with anti-DIG-alkaline phosphatase antibody (1:1000; Roche)
and developed as recommended by the manufacturers instructions
(Roche DIG labeling detection kit). To ensure equivalent conditions
sense and antisense riboprobes were used at equivalent concentra-
tions and run in parallel in the same experiments.
Expression and purification of recombinant proteins
CHO cells expressing secreted NgR2-mFc, NgR2-hFc, and Fc control
proteins were grown for 2 weeks to high density, then the media were
collected and filtered through a 0.45 m filter. Recombinant Fc-fusion
proteins were purified as previously described (Niedero¨st et al., 2002).
Protein concentrationwas determined by the Bradford assay and protein
purity was confirmed by silver staining. Sema3A-mFc and Ephrin4A-hFc
were purchased (R&D Systems). Recombinant untagged human Versi-
can V0 and Versican V1 were produced by transient transfection of
CHO-K1 using jetPEi transfection reagent (Polyplus). After 36 h in cul-
ture, cells were harvested by centrifugation and lysed with radioimmu-
noprecipitation assay buffer (25 mM Tris-HCl, 150 mM NaCl, 1%
1634 • J. Neurosci., January 29, 2014 • 34(5):1633–1646 Ba¨umer et al. • Nogo Receptor Homolog NgR2 Controls Epidermal Innervation
Nonidet P-40, and 0.1% SDS) containing protease inhibitors (Roche).
The lysate was cleared by centrifugation (14,000 g for 20 min at 4°C)
and the supernatant was diluted to 100g/ml total protein before use for
stripe coating in cell culture experiments described below. Recombinant
human Versican V3 was produced as myc-His6 fusion proteins by tran-
sient transfection of CHO-K1 using jetPEi transfection reagent
(Polyplus). Conditioned medium and 1 M NaCl cell extracts were incu-
bated with nickel-agarose beads (Clontech) for 4 h at 4°C. After washing
with PBS containing 10 mM imidazole, bound proteins were eluted with
PBS containing 500mM imidazole. Purity of proteins was determined by
SDS-PAGE followed by silver staining and Western blot analysis with
anti-myc antibody (Sigma-Aldrich). Protein concentration was deter-
mined by the Bradford assay.
Quantitative real-time PCR
Total RNA was isolated by homogenizing frozen lumbar DRGs and
glabrous skin from the hindpaw of WT and NgR2/ mice, using the
Macherey–Nagel NucleoSpin RNA II Kit according to the manufactur-
ers instructions includingDNase I digestion. RNA integrity and concen-
tration were determined by agarose gel-
electrophoresis and by UV absorbance using a
NanoDrop 2000 spectrophotometer (Thermo
Scientific). One to two micrograms of total
RNA was reverse transcribed using RevertAid
First Strand cDNA Synthesis Kit (Fermentas).
Quantitative real-time (qRT)-PCR was per-
formed in a 20 l reaction containing 4 l of
the 1:5 or 1:10 diluted reverse transcribed reac-
tion, 0.5M of each primer (Metabion) and 10
l 2 SsoFast EvaGreen Supermix (Bio-Rad).
Reactions were run in triplicate on an Applied
Biosystems 7500 Fast Cycler. After amplifica-
tion, a dissociation curve was plotted against
melting temperature to ensure amplification of
a single product. Control reactions for every
amplification were run without template and
with the reverse transcriptase control reaction
products as negative controls. Normalized fold
expression of the target gene (i.e., the effect in
NgR2/ mice) was calculated according to
the 		Ct method (Livak and Schmittgen,
2001). Fold change in the amount of target
mRNA was normalized to the housekeeping
gene RPS29. Means of the 	Ct values of four
NgR2/ and four NgR2/ mice were used
to calculate the 		Ct value (		Ct  	Ct
NgR2/  	Ct NgR2/). The SDs of the
fold changes were calculated according to the
Guide to Performing Relative Quantitation of
Gene Expression Using Real-Time Quantitative
PCR (Applied Biosystems) and are expressed as
the range of fold difference. Intron-spanning
primer pairs for murine Neurturin (NTN),
GFR3,TrkA,TrkB, andTrkCweredesignedus-
ing Primer BLAST (National Center for Biotech-
nology Information, NCBI). Specificity was
confirmed by BLAST (NCBI). Possible dimer
formation was analyzed by FastPCR (www.
biocenter.helsinki.fi/bi/programs/fastpcr.htm).
Primer sequences for GFRa1, GFRa2, NGF,
BDNF, GDNF, and NT3 were taken from
Jankowski et al. (2009), and for both isoforms
of c-Ret from Kojima et al. (2011). Primer se-
quences for Asic1a and Asic2a were taken from
Sherwood et al. (2011), and for Asic3a from
Hattori et al. (2009). Additional primers were
used for: NTN (forward: 5-AGCTCCCTGC-
TATCTGTCTGGATG-3; reverse: 5-GAGAA
AGTTCTCGAAGCTCCACC-3); GFR3 (for-
ward: 5-CTTGGTGACTACGAGTTGGATGTC-
3; reverse: 5-AGATTCATTTTCCAGGGTTTGC-3), TrkA (forward:
5-AGGTCTCTGTCCAAGTCAGCGTC-3; reverse: 5-TCTCGTTGAGCA
CAGAGCCGTT-3); TrkB (forward: 5-TGCACGCAAGGACTTTCATC
GGGA-3; reverse: 5-TGTTGGGACGCCAGGTAGACCATA-3); TrkC (for-
ward: 5-AGGTCTTCCTGGCTGAGTGCTACAA-3; reverse: 5-AGGC
TATCTGACTGGCGATGTGGA-3).
Preparation of protein-coated beads and bead aggregation assay
Bead-cell adhesion and bead aggregation assays were performed as pre-
viously described (Marthiens et al., 2005). Aliquots of 100l carboxylate
microsphere suspension (3  108 microspheres/ml, diameter 4.5 m;
Polysciences) were washed with 0.1 M borate buffer, pH 8, and incubated
overnight at 4°C with 20 g of either goat anti-mouse IgG, Fc fragment-
specific antibody (Jackson ImmunoResearch) orVersicanV0/V1-specific
rabbit anti-GAG antibodies. Beads were saturated with 1% bovine se-
rum albumin (BSA) in borate buffer for 15 min. Anti-mouse-Fc beads
were incubated under mixing with 1 g of NgR2-mFc, Sema3A-mFc, or
controlmFc. Beads coupled with anti-GAGwere incubated with lysates
Figure 1. NgR2 is expressed by distinct subpopulations of sensory neurons. A, Representative DRG cross sections of WT and
NgR2/ mice labeled with antisense and sense cRNA probes against NgR2-mRNA. NgR2-negative neurons are encircled by a
yellow line.B, Size distribution of NgR2mRNA-positive and -negative cells in adult DRG. C, Combined ISH of NgR2mRNAwith IHC
(red) for indicated markers. Arrowheads mark double-labeled neurons; arrows indicate marker-positive but NgR2-negative neu-
rons. D, Confocal micrographs of L5 DRG sections from WT and NgR2/ mice stained for CGRP and TrpV1 (both green) or
triple-stained for IB4 (green), P2X3 (red), and NF200 (blue). E, Proportion of neurons stained for indicated markers was similar in
NgR2/ and WT controls. ( p 0.05; n 4). F, Size-frequency histogram illustrating the distribution of the cross-sectional
areas of DRG neurons positive for the indicated markers in WT and NgR2/ mice. Note that the frequency distribution of
marker-expressing neurons is unaffected in NgR2/mice. G, Confocal micrographs of sciatic nerve cross sections fromWT and
NgR2/ mice double stained for the Schwann cell marker S100 (red) and TuJ1 (green). Morphology appeared equal for
NgR2/ andWT littermate controls. Scale bars: A, C, D, G, 40m.
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of Versican V0 or V1-expressing CHO cells (10 g total protein) for 1 h
at room temperature. Purified Aggrecan (5 g; Millipore) or human
MAG (5g; Sino Biologicals) was directly coupled to 50l beads in 0.1 M
borate buffer, pH 8. To quantify amounts of immobilized protein, 20 l
of coated beads were heated (85°C, 10 min) in Laemmli buffer and the
supernatant was used for SDS-PAGE with NuPAGE 4–12% Bis-Tris gels
(Invitrogen). Gels were silver stained or transferred to PVDFmembranes
for Western blots using anti-mFc-Cy3 antibodies. Bands were detected
using SuperSignal West Pico chemiluminescent substrate (Thermo
Fisher Scientific) and quantified using ImageJ (version 1.44o). For the
bead-cell adhesion assay, CHO cells were seeded on 10 mm glass cover-
slips in 48-well plates and transiently transfected with pSecTag-
VersicanV0, pSecTag-VersicanV1, or pSecTag-VersicanV3 constructs.
Cells were cultivated for 36 h before by addition of 2.5l coated beads in
250 l DMEM to each well. Beads were allowed to bind for 45 min at
37°C, 5%CO2. After washing, cells were fixed for 15min with 2%PFA in
PBS and used for immunostaining of VersicanV0/V1 (rabbit anti human
GAG; 1:2000) isoforms as described above. Versican V3 was visualized
through the myc-tag with mouse anti-myc (1:2000; Sigma-Aldrich). For
bead aggregation assays, beads (1l each in 250l DMEM) coupledwith
NgR2-mFc, Sema3A-mFc, or mFc were mixed with beads coupled with
recombinant Versican V0, Versican V1, Aggrecan, or MAG (each 1 l in
250 l DMEM) and allowed to settle on a glass coverslip in a 48-well
format for 45 min at 37°C. Where indicated, the assay was performed
with Versican-coupled beads pretreated for 3 h at 37°C with 0.1 UChon-
droitinase ABC (Sigma-Aldrich). The aggregation index was determined
as (number of counted beads number of beads in aggregates)/number
of counted beads. For each experiment (n), five fields each containing

1000 beads were analyzed. Statistical analysis used unpaired Student’s t
tests (GraphPad Prism, version 5), with statistical significance reported
in the figure legends.
Coimmunoprecipitation and immunoblotting
CHO-K1 cells were cotransfected with the NgR2-hFc or hFc expression
vector in combination with human full-length Versican V3-pSectag, G1-
pSectag, G3-pSectag, or NogoB-pcDNA3.1. Twenty-four hours after
transfection, cells were lysed in precipitation buffer (50 mM Tris-
phosphate, pH 7.4, containing 150 mM NaCl, 0.2% Nonidet P-40, 1%
BSA, 1 mM phenylmethylsulfonyl fluoride, and 2 mg/ml aprotinin) and
centrifuged at 14,000 g for 20min at 4°C. The cell lysate was combined
with the conditioned medium and incubated for 2 h at 4°C with protein
A/G-agarose beads. Beads were washed three times with PBS before the
separation of bound proteins by SDS-PAGE. Immunoblots were probed
using a monoclonal anti-hFc-Cy3 antibody (Sigma-Aldrich) to detect
Figure 2. NgR2-deficientmice display epidermal hyperinnervation of nonpeptidergic fibers. A, Cross sections of the glabrous hindpaw skin of adultWT, NgR2/, and NgR1/mice stained
with TuJ1. Dotted line denotes DEJ. B, Quantification of the total number of TuJ1 nerve endings (NE) per 1000m2 skin area (**p 0.01; n 5 for each genotype). C, Confocal analysis of
Troma-I-labeled MCs (green) or of S100-positive Meissner’s corpuscles (green) innervated by neurons as labeled by NF200 (red). Sections were counterstained with Hoechst (blue). Dotted line
denotesDEJ.D, L5 spinal cord cross sections fromWTandNgR2/mice shownodifference indensity and terminationpatternof CGRP (red), IB4 (green), andNF200 (blue)primaryafferents
in the superficial layers of the dorsal horn. E, Cross sections of the glabrous hindpaw skin of P5WT and NgR2/mice stained for TuJ1 (green) and CGRP (red). Arrowsmark double-labeled fibers.
F, Total number of TuJ1 nerve endings per 1000 m2 skin area is significantly increased in p5 NgR2/ mice (*p 0.05; n 4), while the number of CGRP fibers is unaltered. G, 3D
reconstruction of 20m confocal stacks. Nuclei were counterstained with Hoechst. Arrows indicate TuJ1 terminals in stratum granulosum (SG), arrowheads in stratum spinosum (SS). TuJ1
fibers terminating in stratum granulosum coexpress P2X3 (small images). H, Quantification of TuJ1 nerve endings shows that significantly more nociceptive fibers terminated in the stratum
granulosum in NgR2/mice than in WTmice (*p 0.05; n 4). Scale bars: A, C, D, E, 40m. SB, stratum basalis; SC, stratum corneum.
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hFc only and NgR2-hFc and an anti-myc antibody (Sigma-Aldrich) was
used to detect the full-length Versican V3, the N-terminal G1, the
C-terminal G3, and the full-length NogoB. Membranes were washed
with TBS-T, incubated with appropriate secondary antibodies, and de-
veloped with the Odyssey scanning system (Odyssey CLx; LI-COR). Sec-
ondary antibodies included anti-mouse-IRDye680 (1:20.000; LI-COR)
and anti-rabbit-IRDye800 (1:20.000; LI-COR).
Immunohistochemistry. Lumbar DRGs (L4–L5), sciatic nerve, and gla-
brous hindpaw skin were dissected and fixed for up to 4 h in 4% PFA in
PBS, then cryoprotected in 25% sucrose in PBS at 4°C for at least 24 h and
embedded and frozen in optical cutting medium (OCT; Richard–Allan
Scientific). Spinal cord samples were dissected and immediately snap
frozen with liquid nitrogen. Cryostat sections of 12 m for DRGs and
sciatic nerve and 20 m for skin and spinal cord were mounted on
poly-lysine-coated slides (Thermo Scientific) and blocked in 10% nor-
mal goat serum in PBS containing 0.3% Triton X-100 (PBST) for 1 h,
reacted with primary antibodies at room temperature for 12 h, washed,
and incubated 90 min at room temperature with secondary antibodies.
Primary antibodies included: goat anti-CGRP (1:300; Abcam), mouse
anti-NF200 (1:1000; Sigma-Aldrich), chicken anti-NF (1:1000; gift from
Michaela Kress, Innsbruck Medical University), rat anti-cytokeratin 8
(clone Troma-I, 1:40; Developmental Studies Hybridoma Bank), guinea
pig anti-P2X3 (1:1000;Millipore), rabbit anti-TrpV1 (1:2000; a gift from
Hans-Gu¨nther Knaus, Innsbruck Medical University, Austria), mouse
anti--III-tubulin (clone TuJ1, 1:1000; R&D Systems), rabbit anti-S100
(1:1000; Dakopatts), rabbit anti-PGP 9.5 (1:2000; gift from Anne Zurn,
Lausanne, Switzerland), rabbit anti-mouse Versican V0/V1 (recognizing
the GAG-domain; 1:2000; Dours-Zimmermann et al., 2009), and Alexa
Fluor 488-conjugated IB4 (1:1000; Invitrogen). Secondary antibodies
were Alexa Fluor 488-conjugated goat anti-mouse IgG (1:5000), Alexa
Fluor 568-conjugated goat anti-mouse IgG (1:10,000), Pacific Blue-
conjugated goat anti-mouse IgG (1:1000), Alexa Fluor 633-conjugated
goat anti-rat IgG (1:2000), Alexa Fluor 633-conjugated goat anti-guinea
pig IgG (1:2000), Alexa Fluor 488-conjugated donkey anti-goat (1:2000),
Alexa Fluor 568-conjugated goat anti-chicken IgY (1:10,000), Alexa
Fluor 568-conjugated goat anti-rabbit IgG (1:10,000), and Alexa Fluor
488-conjugated goat anti-rabbit IgG (1:2000; all from Invitrogen). To
stain nuclei, 1:1000 Hoechst (Invitrogen) was added to the secondary
antibodymixture. After washing, sections were imaged using a Leica SP5
confocal microscope or epifluorescence microscope (Axio Imager.M2;
Zeiss). Analysis of immunostaining was performed blinded to genotype.
Images were processed using EMBL ImageJ (V 1.45 h, National Institutes
of Health) or Corel Photopaint X3 software (v13.0.0.576; Corel) using
global adjustments in brightness and contrast. For marker prevalence
analysis, at least 1000 neurons were scored from nonadjacent L4 and L5
DRG sections from four to five mice per genotype. To determine the
percentage of labeled neurons, labeled and nonlabeled profiles were
counted in at least four randomly selected sections (separated by 50
m) per DRG from at least four animals. Additionally, the cross-
sectional soma areas of labeled neurons were measured for at least four
randomly selected sections of four animals usingMetaVue 5.0r3 software
(Universal Imaging).
Epidermal sensory innervation. Quantification of epidermal sensory
innervation density was performed as described previously (Lindfors et
al., 2006). Labeled nerve fibers in the epidermis of at least 10 randomly
chosen confocal micrographs (20 m stacks) of four animals per geno-
type were counted and the fiber density (number of fibers/1000 m2)
was calculated. Imaris software (v6.2 Bitplane AG) was used to recon-
struct 3D models of 10 randomly chosen confocal stacks of four animals
per genotype. The innervation depth of sensory-free nerve endings was
determined bymaking use of surface rendering of the keratinocyte nuclei
to distinguish between the different epidermal layers. Analysis of Merkel
cell-neurite complex (MCs) was performed by thorough focusing of
Troma-I and NF200 double-stained skin sections using an epifluores-
cence microscope (Axio Imager.M2; Zeiss). MCs were counted as prop-
erly innervated if NF200-positive fibers clearly reach the MC surface as
their target. At least 50 randomly chosenMCs of three animals per geno-
type were used for analysis.
Neurite outgrowth and stripe assays. Poly-L-lysine (10g/ml) glass cov-
erslips were first coated overnight with proteins at indicated concentra-
tions at 4°C, followed by 5 g/ml laminin (Sigma-Aldrich) for 2 h at
37°C. DRGs from three to five animals (P2) for each genotype were
dissociated and cultured as described previously (Schweigreiter et al.,
2004). For neurite outgrowth assessment, cells were fixed in 4% PFA for
10 min, washed in PBS, and incubated at 4°C overnight with anti--III-
tubulin antibodies (clone TuJ1; 1:1000 in PBS/0.3% Triton X-100; R&D
Systems). The following day, coverslips were washed and incubated with
Alexa Fluor 488- or 594-conjugated goat-anti-mouse antibody (1:2000;
Invitrogen). Two to three coverslips were assessed per experiment and
10–12 images were randomly taken per coverslip, typically resulting in
150–300 cells/condition. Stripe assays were essentially performed as de-
scribed previously (Dutt et al., 2011). Proteins togetherwith 1g/ml goat
anti-Fc-Cy3 (Sigma-Aldrich) or goat anti-mouse-Pacific Blue (Invitro-
gen) were injected into matrices (90 m width) placed on 22 mm glass
coverslips, resulting in red or blue fluorescent stripes. EphrinA4-Fc was
used in concentrations of 10g/ml, Aggrecan at 5g/ml, Versican V3 at
1g/ml, and Versican V0 andV1 cell lysates at 100g/ml. Ephrin-A4-Fc
was used after preclustering with anti-humanFc-Cy3 antibody (1:5;
Sigma-Aldrich). After incubation for 1 h at 37°C, matrices were carefully
removed and coverslips washed with PBS. The coverslips were further
coatedwith 5g/ml laminin for 1 h at 37°C.DissociatedDRGneurons of
P2 mice were cultured in the presence of 50 ng/ml NGF for 16 h on the
stripe-coated coverslips. After fixation in 1% PFA in PBS for 5 min fol-
lowed by 15min of methanol at20°C, cells were incubated withmouse
anti-NF200 (1:1000) or rabbit anti-PGP 9.5 (1:2000) and Alexa Fluor
488-conjugated IB4 (1:1000). Secondary antibodies were goat anti-
rabbit-Alexa Fluor 568 (1:10,000; Invitrogen), goat anti-mouse-Alexa
Fluor 488 (1:5000), and goat anti-mouse-Pacific Blue (1:2000). The per-
centage of neurons that crossed the stripe border was determined by
counting 30–50 individual neurons per experiment. To block the inhib-
itory effect of Versican V3, stripes were incubated with soluble NgR2-
mFc ormFc at 10g/ml for 45min at 37°C.Neuronswere visualizedwith
rabbit anti-PGP9.5 and stained with Alexa Fluor 488-conjugated IB4.
Statistical analysis. Statistical tests depended on sample size, distribu-
tion, andnumber of variables. The nonparametricMann–WhitneyU test
or the parametric Student’s unpaired two-tailed t test were used for com-
parison between groups, while the Mann–Whitney U test was used for
Figure 3. NgR2-deficient mice display sensory deficits for mechanical pain and cold sensa-
tion. A, Thermal sensitivity measured in WT versus NgR2 knock-out mice, using hot-plate and
cold-plate tests. Values represent the latency (s) for animals to lick their hindpawsor jump (n
8per genotype).B, Response tomechanical forces. Note thatNgR2/micehad lower thresh-
old responses thanWTmice (**p 0.01; n 8 per genotype). C, Thermal preference test. The
time indicated is the fraction spent by the mice on the 30°C plate measured over 5 min.
NgR2/mice spent significantly less time thanWTmice at the 25 and20°C test temperatures
(*p 0.05; n 8 per genotype). Data are presented as mean SEM.
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intra-individual comparisons. All data are expressed as mean SEM. A
value of p 0.05 was considered significant.
Results
NgR2 is expressed by DRG neurons of different
subpopulations
Adult sensory neurons have previously been reported to express
NgR2 (Laure´n et al., 2003; Venkatesh et al., 2005), although a
detailed expression pattern has not been evaluated. Immunohis-
tochemical studies of NgR2 have been compromised by the lack
of specific antibodies; all are commercially available antisera to
NgR2 stain knock-out tissue. We therefore used ISH with DIG-
labeled cRNA probes to NgR2 and found that 
80% (79 
1.36%, n  3) of all mouse L4/5 DRG neurons express NgR2
mRNA at varying levels (Fig. 1A). The in situ probes were tran-
script specific as no signals were seen in tissue fromNgR2 knock-
out mice (Fig. 1A). The size distribution of NgR2-positive
neuronal profiles suggests that NgR2 mRNA is mainly expressed
by small and large diameter neurons, whereas the NgR2-negative
neurons are predominantlymedium sized (Fig. 1B). To relate the
expression of NgR2 to functional DRGneuron subtypes we com-
bined ISH with IHC (Fig. 1C) using the markers NF200 (mecha-
noreceptors and proprioceptors with large axon diameters), IB4
(nonpeptidergic nociceptors), CGRP (peptidergic nociceptors),
and TRPV1 (heat-sensitive nociceptors): 48.36  2.96% of the
NgR2 mRNA-expressing DRG neurons stained for NF200,
40.1 2.34% bound IB4, 29.53 0.59% contained CGRP, and
16.65 0.33% coexpressed TrpV1. Conversely, the vast majority
of IB4-binding neurons (87.03  1.44%) and over 50% of the
CGRP (57.72  3.43%) or TrpV1 neurons (56.56  1.89%)
coexpressed NgR2 mRNA. Almost all NF200 neurons coex-
pressed NgR2 (94.21  2.3%). The results are in line with the
shift of NgR2-negative cells to neurons of medium-sized diame-
ter. No change in the total number of L4/5 DRG neurons (WT,
3821  66; NgR2/, 3763  54; p  0.05; n  4), nor in the
relative percentage of sensory neuron subsets was observed be-
tween genotypes (Fig. 1D,E). Consistently, the size frequency
distributions of different neuronal cell body diameters, charac-
teristic of different DRG neuronal subpopulations, were compa-
rable between NgR2/ and WT mice (Fig. 1F). There were no
obvious differences in the morphology and number of sensory
afferent axons in sections of the sciatic nerve (Fig. 1G). In sum-
mary, the results show that NgR2 is expressed in all sensory
subclasses at various levels, preferentially by small-diameter
IB4 nociceptive and largemechanosensory neurons, but has no
apparent effect on neuronal number and/or differentiation.
NgR2 deficiency increases peripheral but not central afferent
density of nonpeptidergic nociceptors
Because NgR1 is best known for its functions as a suppressor of
anatomic plasticity, we investigated whether NgR2 deletion
changes the peripheral or central projections of sensory neurons.
We compared the peripheral innervation pattern of nociceptive
C-fiber terminals in the glabrous skin of WT and NgR2/mice
using the pan-neuronal marker TuJ1 (-tubulin III). Fiber den-
sity and labeling intensity of the subepidermal nerve plexus in the
footpad dermis appeared similar for all genotypes (Fig. 2A). In
contrast, quantitative measurements of the total number of
TuJ1 fibers in the epidermis showed a 1.5-fold increase of free
nerve endings in NgR2/mice relative toWT animals. (Fig. 2B;
3.59 0.18 nerve endings per 1000 m2 skin for NgR2/ and
2.50 0.25 nerve endings in the control mice; p 0.01, n 5).
Interestingly, this phenotype was not observed in NgR1/mice
(Fig. 2A,B), pointing to a specific role for NgR2 in cutaneous
sensory innervation. Moreover, no NF200 (Fig. 2C) or TH
fibers (data not shown)were observed that innervatedtheepidermis
inNgR2/ animals, excluding the possibility of aberrant sprout-
ing of myelinated proprioceptive or sympathetic fibers, respec-
tively. In addition, afferent innervation of morphologically
distinct mechanoreceptors in the footpad was largely unaf-
fected. As shown in Figure 2C, NF200 nerve endings were
frequently associated with S100-positive cells to form struc-
tures morphologically reminiscent of Meissner’s corpuscles or
withMCs stained with Troma-I (Fig. 2C). Localization of MCs
at the basal layer of the epidermis, their number, and percent-
age of innervated Troma-I-positive cells appeared to be unal-
tered (89.64 2.01% of Troma-I-positive cells was innervated
in NgR2/mice, 88.17 0.4% in control animals, n 3, p
0.01).
Mice lacking axonal NgR2/ showed no visible difference in
the labeling of nociceptive fibers by CGRP or IB4 in the lumbo-
sacral spinal cord, suggesting that the central projections of non-
peptidergic neurons are not affected. Both the staining intensity
and the afferent distribution were indistinguishable from con-
trols (Fig. 2D).We performed double labeling of CGRP and TuJ1
in the footpad and compared the density of CGRP fibers in
NgR2/ and WT control mice at P5 (Fig. 2E), when epidermal
density of CGRP fibers peaks during development (Peters et al.,
2002). As in adult animals, total fiber density was significantly
increased in NgR2/ mice (Fig. 2F; 8.43  0.30 nerve endings
per 1000m2 skin forNgR2/ and 7.20 0.21 nerve endings in
the control mice; p  0.01, n  4), whereas the peptidergic
C-fiber population was unaffected (Fig. 2F; 2.32  0.21 nerve
endings per 1000 m2 skin for NgR2/ and 2.44 0.32 nerve
Figure 4. Expression levels of skin-derived growth factors and their cognate receptors in NgR2/mice are not altered. A, qRT-PCR revealed no significant differences in expression level of the
growth factors NGF, NT3, BDNF, GDNF, and NTN in the skin of NgR2/ compared with control animals. B, Growth factor receptors (GFR1, GFR2, GFR3, c-Ret, TrkA, TrkB, and TrkC) appeared
not to be regulatedonmRNA level inDRGofNgR2/mice. ( p0.5,n4).C, Purinergic receptors (P2X2, P2X3, andP2X6) aswell as acid sensing channels ASIC1a, ASIC2a, andASIC3a appeared
not to be regulated on mRNA level in DRG of NgR2/mice. Data are presented as mean SEM for four animals; samples run in triplicates. Values are normalized to WT expression value.
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endings in the control mice; p 0.5, n 4). This indicates that
nonpeptidergic nociceptive fibers may account for the increased
innervation density. Because IB4-lectin binds strongly to keratin-
ocytes, a direct identification of the nonpeptidergic fibers in the
epidermis is difficult.However, epidermal innervation is spatially
segregated, with nonpeptidergic, MrgD nociceptors terminat-
ing predominantly in the stratum granulosum, and CGRP fi-
bers in the underlying stratum spinosum (Zylka et al., 2005).
High-resolution confocal microscopy and 3D reconstructions of
TuJ1 fibers (Fig. 2G) revealed significantly more TuJ1 fibers
innervating the stratum granulosum in NgR2/ mice than in
WT controls (Fig. 2H; 8.05  0.31 nerve endings per confocal
stack for NgR2/ vs 5.93  0.68 nerve endings in the control
mice; p  0.05, p  0.05, n  4), while the number of fibers
terminating in the stratum spinosum was unaffected (Fig. 2H;
2.53  0.22 nerve endings per confocal stack for NgR2/ and
2.80 0.30 nerve endings in the control mice; p 0.05, n 4).
Moreover, TuJ1 nerve endings termi-
nating in the stratum granulosum ap-
peared to be P2X3 positive, consistent
with the notion that they are nonpeptider-
gic (Fig. 2G).
Hence, NgR2 is essential for cutaneous
peripheral projection of nonpeptidergic
nociceptive neurons both in young and
mature adult mice, but is dispensable for
the integrity of their central projections.
Loss of NgR2 enhances sensitivity to
mechanical stimuli and impairs
cold sensitivity
As an initial means to explore whether ab-
sence of NgR2 and the resulting sensory
hyperinnervation is accompanied by al-
terations in nociception, we examined the
behavioral responses of NgR2/mice to
noxious thermal and mechanical stimuli.
Acute thermal heat pain sensation was
tested using the hot-plate test. The mean
latency of withdrawal of hindpaw fol-
lowed by licking or biting at 55.556°C
was 18.13  3.06 s for NgR2/ and
19.09  1.33 s for NgR2/ littermate
controls (Fig. 3A). The difference between
groups in this heat thermal test was insig-
nificant (p  0.05; n  8). In contrast,
therewas a clear difference in sensitivity to
noxious mechanical pressure. The mean
weight that resulted in a hindpaw with-
drawal in the Randall–Selitto test was
148.67  11.59 g for NgR2/ mice and
89.74  11.25 g for NgR2/ littermate
controls (Fig. 3B; p  0.01; n  8). This
phenotype could not be ascribed to loco-
motory defects as tested by an accelerating
rotarod (data not shown), so we hypoth-
esized that NgR2 receptors on peripheral
terminals contribute to the mechanosen-
sitive phenotype. As hypersensitivity to
mechanical forces often correlates with al-
tered behavioral cold sensitivity (da Costa
et al., 2010), we tested for behavioral dif-
ferences in response to cold. NgR2/
and littermate control mice responded to the cold-plate test with
similar paw withdrawal latencies (Fig. 3A; p  0.05; n  8).
However, a temperature preference assay revealed distinct differ-
ences between genotypes in their ability to discriminate between
warm and cold surfaces. Mice were allowed to explore two adja-
cent plates, with one held at 30°C and the other set at tempera-
tures ranging from 30 to 10°C. The percentage of time spent on
the 30°C surface wasmeasured over a 5min period.When placed
on equal temperatures (both 30°C), neitherWTnormutantmice
displayed a preference, i.e., they spent
50% of the time on each
side (Fig. 3C; p  0.05, n  8). In contrast, when selecting be-
tween 30°C and 25°C or 30°C and 20°C, NgR2/mice exhibited
a significantly stronger avoidance for cooler (or preference for
warmer) temperatures than their WT littermates (Fig. 3C; p 
0.05, n 8). There appeared to be discrimination between nox-
ious cold temperatures (15°C and lower) and 30°C as all mice,
independent of their genotype spent 90% of the time on the
Figure5. Versican repelsNgR2-expressingDRGneurons.A, Confocalmicrographsof cross sectionsof theglabroushindpawskin
of NgR2/ andWTmice stained with TuJ1 (green) and anti-GAG specific for VersicanV0/V1 (red). Expression and distribution
of VersicanV0/V1 was unaltered in NgR2/mice. B, C, Dose-dependent inhibition of WT DRG neurite outgrowth on indicated
substrates from(B) cell lysates and (C) purifiedproteins.D, NgR2 is required forVersican repulsiveactivity.DissociatedDRGneurons
of NgR2/ and control P2micewere grownon alternating stripes coatedwith laminin (L; black) and the indicated substrates (S;
red). Neurons were stained with TuJ1 (green) to visualize axons. Arrows indicate branch points on inhibitory substrate stripes. E,
Quantification of neurons crossing the inhibitory border. NgR2/neuronswere less repelled by Versican V0 or V1. Aggrecan and
Ephrin-A4-Fc were strongly repulsive for DRG neurons of both genotypes (**p 0.01, n 3). Scale bars: A, D, 40m.
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30°C plate (Fig. 3C; p  0.05; n  8).
When the test plate was set to a tempera-
ture of 49°C, both NgR2/ and WT lit-
termates showed a robust avoidance (Fig.
3C) of the hot side. Thus, whereas
NgR2/mice exhibit significant deficits
in cold sensing in the range between 25
and 20°C, they retain a normal response
to noxious cold temperatures and a signif-
icant capacity for heat avoidance.
NgR2 does not affect the expression of
skin-derived growth factors, their
cognate receptors, or mechanosensors
Signaling by GDNF is important for the
epidermal innervation of nonpeptidergic
fibers (Zwick et al., 2002). Chronic as well
as acute intradermal GDNF administra-
tion is associated with lower mechanical
thresholds in cutaneous nociceptors with
no effect on the thermal behavior of the
same neurons (Albers et al., 2006; Bogen
et al., 2008). Furthermore, overexpression
of NTN in the skin led to an increased
sensitivity to cool temperatures (Wang
et al., 2013). We thus analyzed whether
the expression of skin-derived growth
factors and/or their receptors on DRG
neurons was altered in NgR2/ mice.
Comparative analysis of transcripts en-
coding GDNF, BDNF, NGF, NT3, and
NTN in the skin of NgR2/ and control
mice showed no significant difference.
Likewise, the relative mRNA levels of
GFR1/2/3, c-Ret, TrkA, TrkB, and TrkC
were similar in WT and NgR2/ mice
(Fig. 4A,B). Thus, the hypertrophy of
terminal projections in the glabrous
footpad skin of NgR2/mice does not
correlate with levels of skin-derived
neurotrophic factors.
Changes in the mechanosensitivity of
primary afferents could in principle be a
consequence of altered transcription lev-
els of potential mechanosensitive ion
channels or receptors. Purinergic receptors of the P2X family (Xu
et al., 2008; Banerjee et al., 2009; Hsieh et al., 2012), and acid-
sensing ion channels (ASICs) are expressed in sensory neurons of
the DRG and were suggested to be involved in mechanical pain
perception (Price et al., 2000, 2001). For nociception Asic2a and
Asic3a are of particular interest as both are expressed by small-
diameter DRG neurons (García-An˜overos et al., 2001; Duggan et
al., 2002). No difference in the expression of P2X3, P2X2, and
P2X6 was detected in NgR2/ DRGs (Fig. 4C), consistent with
our data that NgR2 knock-out does not alter the ratio of P2X3-
positive DRG neurons to other subtypes (Fig. 1D,E). Like for
P2X channels, no alterations in DRG expression of Asic1a,
Asic2a, or Asic3a were found, suggesting that deficits in the
mechanosensitivity of NgR2/ mice are not due to changes in
channels that potentially mediate mechanosensation. In addi-
tion, loss of NgR2 did not affect the number of neurons that
express TrpM8, a cold temperature-sensitive receptor (data not
shown; Bautista et al., 2007; Colburn et al., 2007).
NgR2 is required to mediate sensitivity to Versican V0/V1
It is tempting to propose that NgR2 signaling at nerve terminals
affects the ability of nonpeptidergic neurons to respond to factors
in the skin that either promote or inhibit axon extension and
branching. To test this idea, we used an in vitro boundary assay
in which DRG axons had to encounter stripes of different
keratinocyte-derived proteins. We focused on two chondroitin
sulfate proteoglycans, Versican and Aggrecan, and on Ephrin4A,
as these proteins are expressed in the skin throughout develop-
ment (Zimmermann et al., 1994; Moss et al., 2005; Malgouries et
al., 2008). Notably, two isoforms of Versican, V0 and V1, are
expressed by keratinocytes and fibroblasts in the proliferating
zone of the epidermis and are released to the extracellular matrix
at the DEJ (Zimmermann et al., 1994). Neither expression nor
localization of Versican V0/V1 was noticeably altered at the
DEJ of NgR2/ mice (Fig. 5A). All substrate molecules tested
significantly inhibited neurite outgrowth ofWTDRGneurons in
a concentration-dependent manner (Fig. 5B,C) as previously re-
Figure 6. NgR2-mFc binds specifically to Versican V0/V1. A, Versican V0 or V1-expressing CHO cells were incubated with
NgR2-mFc or Sema3A-mFc immobilized on polystyrol beads. Expression of Versican isoforms was visualized with anti-GAG
antibodies (green). Nuclei were stained with Hoechst (blue). Note that only NgR2-mFc beads bound to Versican-expressing CHO
cells. B, Western blot, probed with anti-mFc, confirming similar coating efficiency of NgR2-mFc and control Sema3A-mFc used in
bead aggregation assays. Note that NgR2-mFc is highly glycosylated, resulting in a broader band. C, Beads coatedwith NgR2-mFc
weremixedwithbeads coupledwith indicatedproteins andanalyzed for their aggregationbehavior. Similar resultswere observed
when Versican-coated beads were pretreated with Chondroitinase ABC. D, Quantitative analysis of bead aggregation shows that
NgR2-mFc covered beads aggregatedwith beads coatedwith Versican orMAG, but notwith Aggrecan. E, ControlmFc or Sema3A-
mFc beads remained largely monomeric. Scale bars: A, C, 40m.
1640 • J. Neurosci., January 29, 2014 • 34(5):1633–1646 Ba¨umer et al. • Nogo Receptor Homolog NgR2 Controls Epidermal Innervation
ported (Borisoff et al., 2003; Moss et al., 2005; Dutt et al., 2011).
When perinatalWTDRG neurons were grown in the presence of
NGF to select for nociceptive neurons, on alternating lanes of
laminin and Versican (Fig. 5D), almost 60% of the dissociated
neurons grew preferentially on the permissive laminin lanes but
failed to extend neurites past the border of Versican V0 or Versi-
can V1-enriched stripes (Fig. 5D,E). In contrast, neurites were
able to cross unimpeded onto lanes enriched in MOG (Fig.
5D,E). Interestingly, the proportion of NgR2/ DRG neurons
with neurites that crossed the border onto the Versican V0 or V1
substrates was30%higher than that ofWTneurons (Fig. 5D,E;
72.41  3.36% NgR2/ neurons cross onto Versican V0 and
71.03 2.41% onto Versican V1 vs 44.04 1.44% of WT neu-
rons crossing onto Versican V0 and 42.1 1.32% onto Versican
V1, n  3, p  0.01). No difference in crossing frequency was
observed between WT and knock-out neurons at the laminin/
Aggrecan or laminin/EphrinA4-Fc border (Fig. 5D,E). Therewas
also an increase in the incidence of crossed fibers forming collat-
eral branches on the Versican lanes (1.00  0.27 branch points
per neurite on V0 for NgR2/ neurons vs 0.34  0.10 branch
points per neurite for WT neurons; p 0.05, n 4). This effect
was not observed at the laminin/Ephrin-A4 border. As deletion of
NgR2 significantly attenuated Versican-induced repulsion of
DRG neurons, we concluded that NgR2 is required for Versican
inhibitory activity.
In vitro binding of NgR2-mFc to Versican isoforms
To investigate whether the ectodomain of NgR2 interacts with
Versican V0 or V1, NgR2-mFc fusion proteins bound to polysty-
rol beads were tested for the ability to bind to CHO cells express-
ing untagged recombinant Versican V0 or V1 proteins (Fig. 6A).
Staining with anti-GAG antibodies verified that the Versican
isoforms are expressed and secreted by the transfected cells. NgR2
beads specifically bound to Versican isoform-expressing CHO
cells but not to control cells. Beads covered with equivalent levels
of Sema3A-mFc (Fig. 6B) served as controls (Fig. 6A). To exam-
ine the interaction of NgR2 and Versican V0 or V1 in a cell-free
experiment, we used a bead aggregation assay (Fig. 6C). NgR2-
mFc beads were incubated with beads coated with purified
recombinant Versican V0 or V1proteins. Negative controls in-
cluded beads with mFc-tag or Sema3A-mFc and beads coated
with purified Aggrecan. MAG-coated beads were used as a posi-
tive control. NgR2-mFc beads were largely monomeric (90.36
2.13%) at the start of the incubation period. Bead aggregation
was monitored after a 45 min incubation period. NgR2-mFc was
found to promote aggregates consisting of two or more beads
when incubated with Versican V0 or V1 (Fig. 6D; 64.52 0.66%
of beads in aggregates for Versican V0; 55.92 7.12% for Versi-
can V1; n  3). Similar aggregation properties were found be-
tween NgR2 and its known high-affinity binding partner MAG
(Fig. 6D; 71.34  5.71%; n  3), whereas Aggrecan (Fig. 6D;
15.73  2.03%), mFc-tag, or beads loaded with Sema3A-mFc
(Fig. 6E; 21.58  2.51% and 18.83  0.7%) did not aggregate,
highlighting the specificity of NgR2 binding for Versican (Fig.
6D,E). Prior digestion of Versican beads with Chondroitinase
ABC did not significantly affect bead aggregation (Fig. 6C,D;
54.9 3.84% of beads in aggregates for digested VersicanV0 and
61.95  5.62% for VersicanV1; n  3), suggesting that NgR2
binding does not depend on GAG side chains of the Versican
isoforms. Although the results do not exclude a possible contri-
bution of residual GAG stubs in the NgR2/Versican interaction,
our data are in line with recent biochemical findings demonstrat-
ing that NgR2, in contrast to its homologs NgR1 and NgR3, does
not associate specifically with GAG chains (Dickendesher et al.,
2012). Instead, NgR2 probably interacts with the protein core of
Versican isoforms.
NgR2 binds to the C-terminal G3 domain of Versican
To address this point in more detail, we performed NgR2-Fc
binding assays to Versican V3. Versican V3 is the shortest Versi-
can splice variant, consisting of the N-terminal G1 and
C-terminal G3 domains, shared by all Versican isoforms, but
lacking the domain for GAG chain modification (Fig. 7A). In the
cell-based binding assay, NgR2-mFc beads bound effectively to
Versican V3-transfected cells, but not to MOG-transfected cells.
Moreover, no binding of Sema3A-mFc beads to V3-expressing
CHO cells was observed, supporting the specificity of the
NgR2–V3 interaction (Fig. 7B). We also noted that the neurite
extension of WT DRG neurons was strongly repelled in a dose-
dependent manner by Versican V3 substratum (Fig. 8A). In the
border assay, at 1 g/ml Versican V3, the repulsive effect was
significantlymore pronounced for nonpeptidergic IB4neurons
than for IB4/NF200 (presumably peptidergic) neurons (Fig.
8B,C; 50.09 4.1% IB4 neurons were repelled compared with
28.69  0.96% IB4/NF200 neurons; p  0.05; n  3), while
large NF200 neurons appeared to be unaffected (Fig. 8B,C).
Remarkably, Versican V3 had no significant effect on NgR2/
neurons: neurites of both IB4 and IB4 cells freely crossed onto
Versican V3-coated stripes (Fig. 8B,C; 93.44 1.04% IB4 and
94.05 1.75% IB4/NF200 neurons crossed; p 0.01; n 3),
suggesting that NgR2 is necessary for repulsion by Versican V3.
Importantly, Versican V3 activity could be abolished by pre-
Figure7. NgR2-mFc binds to the shortest Versican isoform, Versican V3.A, Structuralmodel
of Versican isoforms used for in vitro experiments. The longest version, Versican V0, consists of
the G1, GAG-, GAG-, and G3 domains. Versican V1 lacks the GAG- domain. Versican V3 has
no GAG attachment site and thus consists only of the G1 and G3 domains. B, Binding of NgR2-
mFc or Sema3A-mFc beads to CHO cells expressing Versican V3 or MOG. Versican V3 was visu-
alizedwith anti-myc (green), MOGwith anti-MOG antibodies (green). Nuclei were stainedwith
Hoechst (blue). Scale bar, 40m.
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incubation with soluble NgR2-mFc but not with control mFc
(Fig. 8 D,E; 85.55 2.16% of IB4 neurons and 95.42 0.24%
of IB4 neurons grew over the Versican V3-coated stripes; p 
0.001, p 0.05; n 3), strongly suggesting that growth repulsion
wasmediated byNgR2. Tomap the NgR2 binding domain in V3,
CHO cells were transiently cotransfected with NgR2-hFc and a
number of different Versican deletion constructs. Full-length
Versican V3 and the G3 domain were readily coimmunoprecipi-
tated with NgR2-hFc fusion protein but not in the control exper-
iments with control hFc, or when NgR2-hFc was cotransfected
with NogoB-myc (Fig. 9A,B). This result supports the specificity
of the interaction and suggests that theG3domain is sufficient for
NgR2 binding.
In summary, our findings suggest that the NgR2/Versican in-
teraction at theDEJ controls the density of epidermal fiber inner-
vation by specifically suppressing branching and/or innervation
of nonpeptidergic sensory afferents (Fig. 9C).
Discussion
Loss of NgR2 enhances innervation density of nonpeptidergic
nociceptive fibers in epidermal skin
A striking finding of our study is the enhanced density of non-
peptidergic nerve endings in adult NgR2/mouse footpad (Fig.
2), while density and projection of peptidergic fibers remain un-
affected by NgR2 deficiency. Epidermal innervation density of
nonpeptidergic nociceptive fibers in the mouse is largely regu-
lated by the accessibility of GDNF GFLs present in the skin,
whereas peptidergic fibers depend on NGF. Transgenic mice
overexpressing GDNF in keratinocytes show a prominent hyper-
innervation of nociceptive fibers in footpad epidermis (Zwick et
al., 2002). Conversely, mice deficient in Ret or GDNF family
receptor 2 (GFR2), the main coreceptor of Ret in nonpepti-
dergic neurons, display a drastic decrease in nonpeptidergic free
nerve endings in footpad epidermis with no effect on peptidergic
Figure 8. Versican V3 repels NgR2-expressing DRG neurons. A, Dose-dependent outgrowth inhibition of WT DRG neurons by Versican V3 substrate. B, Dissociated DRG neurons of P2 NgR2/
andWTmicewere grown on stripes coated alternately with Laminin (L; black) and Versican V3 (blue). Neuronswere triple stainedwith the pan-axonalmarker PGP9.5 (red), anti-NF200 (blue), and
IB4 (green). Arrows indicate IB4 and arrowheads IB4 neurons. Note that NgR2/ neurons were not repelled by Versican V3 stripes. C, Quantification shows that the percentage of IB4WT
neurons repelled by Versican V3was significantly higher than that of IB4neurons. Note that NgR2/neurons lost their sensitivity to Versican V3 (*p 0.05, **p 0.01; n 3).D, Dissociated
DRG neurons ofWT P2micewere grown on alternating stripes coatedwith purified Versican V3 in the presence of soluble NgR2-mFc ormFc control. Neuronswere stainedwith PGP9.5 (red) and IB4
(green). Arrows indicate IB4 and arrowheads IB4 neurons. E, Quantitative analysis shows that the percentage of IB4-binding neurons repelled by Versican V3 was remarkably reduced upon
blocking with NgR2-mFc, but was not affected upon addition of mFc-only (*p 0.05, ***p 0.001, n 3). Scale bars: B, D, 40m.
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innervation (Lindfors et al., 2006; Luo et al., 2007; Golden et al.,
2010; Franck et al., 2011). Similarly, upregulation of trophic fac-
tors in skin diseases or following wound injuries stimulates ax-
onal sprouting resulting in hyperinnervation (Tominaga et al.,
2008). Likewise, overexpression of NTN in the skin results in
hypersensitivity to cooling, a similar phenotype we found in
NgR2/mice (Wang et al., 2013). However, mRNA expression
levels for all of the growth factors tested and their respective
receptors were comparable between WT and NgR2/ mice.
Furthermore, consistent with a role for target-derived signals in
the growth and maintenance of cell size in the DRG, adult DRGs
fromNgR2/mice are normal in size and showno change in the
overall density of IB4 and CGRP neurons or in their average
somal diameter. Hence, it seems rather unlikely that hyperinner-
vation is the result of increased accessibility to GFLs or of mod-
ulation of the levels of critical growth factor receptors. We
therefore conclude that NgR2 signaling at nerve terminals affects
the ability of nonpeptidergic neurons to respond to factors in the
skin that promote or inhibit axon extension and branching. In-
terestingly, the hyperinnervation phenotype seems to be target
dependent, as the central projections of sensory DRGs are grossly
normal inNgR2/mice. This suggests that the absence of NgR2
signaling does not change the responsiveness of sensory neurons
to signals that regulate central terminal branching within the
spinal cord. Branching of these central projections may depend
upon the Slit family of guidance factors (Ma and Tessier-Lavigne,
2007) and Wnt family proteins for specifying the location of ter-
minal arborization (Krylova et al., 2002).
NgR2 is required to mediate sensitivity to Versican
We show that skin-derived Versican is a novel interaction
partner of NgR2 and is thus a likely candidate for controlling
the density of nonpeptidergic fibers in the epidermis. Versican
has a tridomain structure with an N-terminal region (G1 do-
main) responsible for binding hyaluronate, a central domain
(G2) that carries the GAG side chains (GAG domain), and a
C-terminal globular region (G3 domain) that interacts with
simple carbohydrates and other proteins (Zimmermann and
Ruoslahti, 1989). Alternative splicing generates four different
isoforms of versican (V0 to V3; Fig. 7A; Dours-Zimmermann
and Zimmermann, 1994). Versican V2 is primarily found in
the CNS, while Versican V0 and V1, and in some species V3,
are produced and secreted by proliferating basal keratinocytes
and are the most prominent extracellular matrix proteogly-
cans at the DEJ (Zimmermann et al., 1994). In the developing
nervous system Versican V0/V1 seems to act as barrier mole-
cules affecting neural crest cell migration (Landolt et al., 1995;
Dutt et al., 2006) and axonal growth of sensory neurons (Dutt
et al., 2011). Our stripe-choice assays are consistent with this
function. Nociceptive IB4-binding neurons deficient in NgR2
cross the border into the Versican-enriched lane more fre-
quently and elaborate collaterals on this normally repulsive
substrate. The effect was specific for Versican, and was not
observed with EphrinA4, a repulsive guidance cue present in
early postnatal epidermis (Moss et al., 2005) or for Aggrecan,
a structurally closely related member of the hyalectan family
(Bandtlow and Zimmermann, 2000). Previous studies have
shown that the main inhibitory action of Aggrecan is mediated
through its glycan chains and requires the previously identi-
fied CSPG receptors RPTP and LAR (Shen et al., 2009; Fisher
et al., 2011; Tan et al., 2011). However, NgR2 does not associ-
ate with chondroitin sulfate GAG chains (Dickendesher et al.,
2012), and this explains the persistent sensitivity of NgR2/
neurons to Aggrecan inhibition even at lower concentrations.
In contrast to Aggrecan, the repulsive activity of Versican
V0/V1 for sensory neurons is only partially released by Chon-
droitinase ABC treatment and has thus been mainly attributed
to its protein core rather than to its GAG chains (Dutt et al.,
2011), despite the lack of direct evidence. We now demon-
strate that Versican V3, the smallest splice variant lacking
GAGs, effectively repels sensory neurons in a dose-dependent
manner and that loss of NgR2 is sufficient to abolish neurite
inhibition even at higher Versican V3 concentrations. NgR2
seems to bind selectively to the C-terminal G3 domain, which
is shared by all Versican variants, showing that interaction
between NgR2 and Versicans does not depend on the presence
of a GAG chain. Our findings also imply that Versican variants
can act via different receptor complexes to elicit their repulsive
effects: binding to NgR2 through the G3 domain and/or to
CSPG receptors through the GAG chains. It is conceivable that
axons of specific sensory subclasses may respond differentially
Figure 9. NgR2 interacts with the G3 domain of Versican. A, CHO cells were transiently
transfected with NgR2-hFc or pCMV-hFc together with V3-myc or NogoB-myc as indicated. Fc
proteins were immunoprecipitatedwith Protein A/G agarose.Western blot shows that V3-myc
coprecipitated with NgR2-hFc. B, CHO cells transiently transfected with NgR2-hFc, G1-myc,
G3-myc, NogoB-myc, and pCMV-hFc as indicated were precipitated with Protein A/G agarose.
Western blot shows that G3-myc but not G1-myc coprecipitated with NgR2-hFc. C, Schematic
illustration of the in vivo and in vitro outgrowth phenotype of IB4 DRG neurons in NgR2/
mice compared with WT controls.
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to Versicans, depending on their composition of their Versi-
can receptors. Our observation of striking cell-type-specific
differences in the sensitivity to Versican V3 in vitro is consis-
tent with this interpretation. IB4-binding neurons were
strongly repelled by V3, whereas peptidergic neurons were
only moderately affected and large NF200 neurons seemed
to be insensitive, although the vast majority of them express
NgR2-mRNA, which on first sight does not seem consistent
with the idea that NgR2 and Versican represent a ligand-
receptor pair. The discrepancy may be explained by the fact
that not all peptidergic neurons express NgR2. In addition, we
do not know the actual levels of NgR2 receptor proteins on
DRG axons from different subclasses, so it is unclear whether
this phenotype results from a reduced NgR2 surface expres-
sion or from a lack of potential coreceptors required for NgR2-
signaling. The NgR receptor complex contains both, the NgR
and either the neurotrophin receptor p75NTR or the orphan
receptor TNF family member TROY (Mironova and Giger,
2013), but the functional signaling partner for NgR2 in sen-
sory DRG neurons is currently unknown. A recent study sug-
gests that NgR2 associates with TROY to limit synapse
formation of hippocampal neurons in vitro (Wills et al., 2012).
TROY seems to be expressed by all subclasses of DRG neurons
(Park et al., 2005), whereas at postnatal stages p75NTR is ex-
pressed exclusively by IB4-negative sensory neurons (Molliver
and Snider, 1997). Our results clearly indicate that IB4 axons
display increased sensitivity to V3-induced repulsion com-
pared with IB4/NF200 axons, which correlates with the
selective increase of nonpeptidergic fibers in vivo. Further-
more, the fact that the density of CGRP and NF200 fibers is
not increased in the NgR2-null background indicates that ad-
ditional signals restrict the penetration of sensory fibers in the
epidermis and/or suppress terminal arborization. A decreased
production of Sema3A by atopic keratinocytes has been sug-
gested to account for the hyperinnervation of CGRP fibers in
atopic eczema (Tominaga et al., 2008).
NgR2/mice exhibit sensory defects
Our results are similar to those in a recent report identifying
Laminin-332, another major component of the dermo-epi-
dermal skin basementmembrane, as a local suppressor of sensory
terminal branching and mechanosensitivity currents, a function
it exerts by preventing the formation of protein tethers (Chiang et
al., 2011). In combination with our data these findings show that
the matrix environments between dermis and epidermis are dis-
tinct and may act as important barriers to control the branching
of specific subtypes of sensory afferents.Whether Versican exerts
modulatory effects on the mechanosensitivity of sensory neu-
rons, as shown for Laminin-322, remains to be determined. De-
letion of NgR2 significantly increased acute mechanical
sensitivity but not heat sensitivity. The lack of a deficit in sensing
heat pain is interesting given the polymodal properties of many
nociceptive neurons (Jankowski et al., 2012) but is consistent
with our finding that the number of TrpV1 neurons and its
expression are unaffected by NgR2 deficiency. Whether the in-
creased density of nonpeptidergic afferents contributes to the
increasedmechanical sensitivity we observed inNgR2/mice is
presently unclear. However, greater axonal branching may result
in greater summation of depolarizing potentials evoked by local
factors. Since our results did not appear to showmuch change of
known mechanosensors at the transcriptional level in the DRG,
further studies are required to reveal whether the enhanced
mechanosensitivity might instead be due to alterations in the
localization or composition of mechanosensors and/or central
processing of mechanical signals.
In summary, we report a novel role for NgR2 as a suppressor
of terminal branching of nociceptive nonpeptidergic afferents
during epidermal innervation. Loss of NgR2 leads to increased
innervation of sensory endings in the epidermis, associatedwith a
hypersensitivity to mechanical pain and cold sensation. Com-
bined with the recent findings that NgR1 is an important stabi-
lizer of neuronal connectivity in the brain, the identification of
NgR2 as a receptor for Versican variants provides insights into
the function of these molecules in the CNS and peripheral ner-
vous system.
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